The evaluation of gender on the pharmacokinetics (PK) of pegylated liposomal anticancer agents.

被引：0
|
作者：
La-Beck, N. M.
Wu, H.
Infante, J. R.
Jones, S. F.
Burris, H. A., III
Keedy, V. L.
Kodaira, H.
Ikeda, S.
Ramanathan, R. K.
Zamboni, W.
机构：
[1] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Sarah Cannon Res Inst & Tennessee Oncol, Nashville, TN USA
[4] Sarah Cannon Res Inst, Nashville, TN USA
[5] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[6] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[7] Yakult Honsha, Tokyo, Japan
[8] Virginia G Piper Canc Ctr & TGen, Scottsdale, AZ USA
[9] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13003
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Allometric scaling of the pharmacokinetics of pegylated liposomal anticancer drugs
    Caron, Whitney P.
    Clewell, Harvey
    Dedrick, Robert
    Ramanathan, Ramesh K.
    Yu, Ning
    Schellens, Jan H.
    Beijnen, Jos H.
    Zamboni, William C.
    CANCER RESEARCH, 2011, 71
  • [2] Meta-analysis of the pharmacokinetic variability of liposomal anticancer agents compared with nonliposomal anticancer agents.
    Sidone, B.
    Zamboni, B. A.
    Zamboni, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Correlation of toxicity and efficacy with pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) (Caelyx®)
    Marye J. Boers-Sonderen
    Carla M. L. van Herpen
    Winette T. A. van der Graaf
    Ingrid M. E. Desar
    Mirjam G. W. Arens- van der Logt
    Yvo M. de Beer
    Petronella B. Ottevanger
    Nielka P. van Erp
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 457 - 463
  • [4] Correlation of toxicity and efficacy with pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) (CaelyxA®)
    Boers-Sonderen, Marye J.
    van Herpen, Carla M. L.
    van der Graaf, Winette T. A.
    Desar, Ingrid M. E.
    Arens-van der Logt, Mirjam G. W.
    de Beer, Yvo M.
    Ottevanger, Petronella B.
    van Erp, Nielka P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) : 457 - 463
  • [5] Evaluating the effects of bortezomib (Velcade®) on the pharmacokinetics (PK) of pegylated liposomal doxorubicin (Doxil®, PLD)
    La-Beck, Ninh M.
    Walko, Christine M.
    Scoggins, Lakia
    Dees, E. Claire
    Orlowski, Robert Z.
    Wu, Huali
    Amantea, Michael
    Fardin, Mahsa
    Zamboni, William
    CANCER RESEARCH, 2012, 72
  • [6] Allometric scaling of pegylated liposomal anticancer drugs
    Whitney P. Caron
    Harvey Clewell
    Robert Dedrick
    Ramesh K. Ramanathan
    Whitney L. Davis
    Ning Yu
    Margaret Tonda
    Jan H. Schellens
    Jos H. Beijnen
    William C. Zamboni
    Journal of Pharmacokinetics and Pharmacodynamics, 2011, 38 : 653 - 669
  • [7] Design, synthesis and evaluation of a new class of flavonoids as anticancer agents.
    Georg, GI
    Vogeti, L
    Ahn, YM
    Himes, RH
    Mitscher, LA
    Liu, CJ
    Hanson, P
    Roby, KF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U29 - U29
  • [8] Allometric scaling of pegylated liposomal anticancer drugs
    Caron, Whitney P.
    Clewell, Harvey
    Dedrick, Robert
    Ramanathan, Ramesh K.
    Davis, Whitney L.
    Yu, Ning
    Tonda, Margaret
    Schellens, Jan H.
    Beijnen, Jos H.
    Zamboni, William C.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2011, 38 (05) : 653 - 669
  • [9] Factors affecting the pharmacokinetics (PK) and pharmacodynamics (PD) of nanoparticle and nanosomal anticancer agents
    Zamboni, W.
    Wu, H.
    La-Beck, N.
    Gehrig, P.
    Song, G.
    Walsh, M. H. S.
    Gabizon, A.
    Ramanathan, R.
    Caron, W.
    EJC SUPPLEMENTS, 2010, 8 (07): : 17 - 17
  • [10] The impact of five different administration intervals on the pharmacokinetics (PK) of paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) combination
    Cattel, Luigi
    Milla, Paola
    Cerutti, Eleonora
    Pedani, Fulvia
    Airoldi, Mario
    Crova, Alice
    ANNALS OF ONCOLOGY, 2007, 18 : 82 - 83
12345